Bollard Group LLC Enanta Pharmaceuticals Inc Transaction History

Bollard Group LLC

  • $3.54 Billion
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 12, 2022
SELL
$38.13 - $76.93 $14,603 - $29,464
-383 Closed
0 $0
Q3 2020

Nov 12, 2020
SELL
$43.36 - $53.53 $52,378 - $64,664
-1,208 Reduced 75.93%
383 $18,000
Q2 2020

Aug 13, 2020
BUY
$46.37 - $57.58 $73,774 - $91,609
1,591 New
1,591 $80,000

Others Institutions Holding ENTA

# of Institutions
100
Shares Held
21M
Call Options Held
10.4K
Put Options Held
2.3K
View Full List

About ENANTA PHARMACEUTICALS INC

ENTA Quotes by TradingView
  • Ticker ENTA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 20,724,900
  • Market Cap $233M
  • Description
  • Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Its research and development disease targets include respiratory syncytial virus, SARS-CoV-2, human metapneumovirus, and hepatitis B virus. The company has a collaborative development and li...
More about ENTA
Track This Portfolio

Track Bollard Group LLC Portfolio

Follow Bollard Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bollard Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bollard Group LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email